期刊文献+

肾病综合征兔肝脏获得性表达apobec-1降脂效应及可能机制 被引量:1

The lipid - lowering effect and possible mechanism of apobec - 1 in nephrotic syndrome rabbits
原文传递
导出
摘要 目的观察肝脏获得性表达apobec-1对肾病综合征(NS)兔血脂代谢及肝脏低密度脂蛋白受体(LDLR)、低密度脂蛋白受体相关蛋白(LRP)表达的影响,探讨Ns兔apobec-1降脂效应及其可能机制。方法30只健康雄性普通级新西兰兔随机分为假手术组、Ns组、apobec-1治疗组,每组10只。Ns组、apobec-1治疗组适应性喂养1周后行左肾切除术,术后1周耳缘静脉注射阿霉素(4mg/kg)构建Ns模型;术后11周apobec-1治疗组耳缘静脉注射apobec-1重组腺病毒(1×10^13病毒颗粒/kg)。术后12周处死所有兔,并摘除右侧肾脏和肝脏,留取血液及24h尿液,检测24h尿蛋白(24UPr)、清蛋白(A1b)、尿素氮(BUN)、肌酐(Cr)、血脂等指标,HE染色观察肾脏病理,Western blot检测肝脏LDLR、LRP蛋白表达水平。结果1.假手术组、Ns组及apobec.1治疗组3组之间比较显示24UPr(F=42.778,P=0.000)、Alb(F=3.819,P=0.034)、BUN(F=6.562,P=0.005)、Cr(F=16.076,P=0.000)、总胆固醇(TC,F=17.531,P=0.000)、三酰甘油(TG,F=6.192,P=0.006)、极低密度脂蛋白(VLDL—C,F=6.192,P=0.006)、低密度脂蛋白(LDL.C,F=34.924,P=0.000)、载脂蛋白B100(ApoB100,F=5.180,P=0.012)、载脂蛋白B48(ApoB48,F=6.161,P=0.006)差异均有统计学意义。2.与假手术组比较,Ns组24UPr、BUN、Cr、TC、TG、VLDL—C、LDL—C、ApoB100明显升高,而Alb明显降低,差异均有统计学意义(P均〈0.05)。3.与Ns组比较,apobec-1治疗组Tc、TG、VLDL—C、LDL.C、ApoB100、ApoB48明显降低,差异均有统计学意义(P均〈0.05)。4.与假手术组比较,apobec.1治疗组24UPr、BUN、Cr明显升高,而Alb、ApoB48明显降低,差异均有统计学意义(P均〈0.05)。5.Western blot结果显示3组之间LRP(F=44.180,P=0.000)、LDLR(F=63.141,P=0.000)差异具有统计学意义,与假手术组、Ns组比较,apobec.1治疗组肝脏LDLR蛋白表达明显下调(P〈0.01、0.05);LRP蛋白表达明显上调(P均〈0.01)。结论NS肝脏获得性表达apobec-1可通过上调LRP,加速ApoB48-脂蛋白的清除,进而起到一定降脂效应。 Objective To observe the effect of liver acquired expression of apobec - 1 on blood lipid metabolism, hepatic low density lipoprotein receptor (LDLR), and hepatic low density lipoprotein receptor related protein (LRP) in nephrotic syndrome(NS) rabbits and to explore the lipid - lowering effect and possible mechanism. Methods Thirty healthy ordinary level male new Zealand rabbits were randomly divided into 3 groups:sham operation group ( n = 10) , NS group( n = 10) , and apobec - 1 treatment group( n = 10). Adaptive feeding was given for 1 week, then NS group and apobec - 1 treatment group underwent left nephrectomy, and 1 week later, adriamycin (4 mg/kg) was used to construct the NS model by way of ear vein injection. In the 11 th week after operation, apobec - 1 recombinant adenovirus ( 1 ~ 1013 virus/kg) was injected through ear vein in apobec - 1 treatment group. The 12th week after operation, all rab- bits were sacrificed. Right kidney, liver, blood and 24 hour urine were collected. In 3 groups, 24 hour urinary protein (24UPr) , albumin (Alb) , blood urea nitrogen (BUN) , creatinine (Cr) , blood lipid were detected. Renal pathology was observed by means of HE staining. Expressions of liver LDLR, LRP were observed by using Western blot. Results ( 1 ) There were significant differences among the 3 groups in 24UPr ( F = 42. 778, P = 0. 000) , Alb ( F = 3. 819, P = 0.034),BUN (F=6.562,P=0.005),Cr (F=16.076,P=0.000),total cholesterol (TC) (F=17.531,P= 0. 000 ), total triglyceride (TG) ( F = 6.192, P = 0.006 ), very low density lipoprotein ( VLDL - C ) ( F = 6. 192, P = 0.006) ,low density lipoprotein ( LDL - C ) ( F = 34. 924, P = 0. 000 ) and apolipoprotein B100 (ApoB100) ( F = 5. 180,P =0. 012) and apolipoprotein 1348 (ApoB48) (F=6. 161 ,P =0. 006). (2) Compared with the sham opera- tion group,NS group showed that 24UPr, BUN, Cr,TC,TG, VLDL- C, LDL- C, ApoB100 increased, but Alb decreased, and there was statistical significance ( all P 〈 0.05 ). ( 3 ) Compared with NS group, apobec - 1 treatment group showed that TC, TG, VLDL - C, LDL - C, ApoB100, ApoB48 decreased, and there were statistical significances ( all P 〈 0.05). (4) Compared with the sham operation group,apobec- 1 treatment group showed that 24UPr, BUN, Cr increased, but Alb, apolipoprotein 1348 ( ApoB48 ) decreased, there were statistical significances ( all P 〈 0.05 ). (5) There were significant differences of hepatic protein expression among the 3 groups in LRP( F = 44. 180, P = 0. 000), LDLR (F = 63. 141, P = 0. 000). Compared with the sham operation group and NS group, apobec - 1 treatment group showed that the expression of LRP was up - regulated (P 〈 0.01,0.05 ) , while the expression of LDLR was down - regulated (all P 〈 0.05 ). Conclusions When liver acquired expression of apobec - 1 in NS, it could up - regulate LRP, accelerate the elimination of ApoiM8 - lipoproteins, and produce a certain lipid - lowering effect.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2015年第17期1317-1320,共4页 Chinese Journal of Applied Clinical Pediatrics
基金 安徽省自然科学基金(1208085MH153)
关键词 低密度脂蛋白受体 低密度脂蛋白受体相关蛋白 肾病综合征 apobec-1 Low density lipoprotein receptor Low density lipoprotein receptor related protein Nephrotic syndrome apobec - 1
  • 相关文献

参考文献14

  • 1张碧丽,王健.肾病综合征患儿的脂代谢紊乱[J].中华实用儿科临床杂志,2013,28(5):398-400. 被引量:11
  • 2VaziriND.Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease[J].Clin Exp Nephrol, 2014, 18(2):265-268.
  • 3BraamskampMJ, WijburgFA, WiegmanA.Drug therapy of hypercholesterolaemia in children and adolescents[J].Drugs, 2012, 72(6):759-772.
  • 4JiangZ, GongRR, QiuL, et al.Efficacy and safety of pitavastatin versus simvastatin:a meta-analysis of randomized controlled trials[J].Clin Drug Investig, 2014, 34(9):599-608.
  • 5QianX, BalestraME, YamanakaS, et al.Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors[J].Arterioscler Thromb Vas Biol, 1998, 18(6):1013-1020.
  • 6KozarskyKF, BonenDK, GiannoniF, et al.Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme(apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits[J].Hum Gene Ther, 1996, 7(8):943-957.
  • 7TengB, IshidaB, ForteTM, et al.Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme(Apobec1)[J].Arterioscler Thromb Vas Biol, 1997, 17(5):889-897.
  • 8GoGW, ManiA.Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis[J].Yale J Biol Med, 2012, 85(1):19-28.
  • 9姜梦婕,肖子正,蒋小云,容丽萍,曹飞,崔飞环,吴泽深,谭磊.单中心28年儿童原发性肾病综合征临床与病理分析[J].中华实用儿科临床杂志,2013,28(17):1310-1314. 被引量:16
  • 10HanS, VaziriND, GollapudiP, et al.Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome[J].Am J Transl Res, 2013, 5(2):246-253.

二级参考文献38

  • 1Moorhead JF,Chan MK,E1-Nahas M. Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease[J].The Lancet,1982,(8311):1309-1311.
  • 2De Seigneux S,Martin PY. Management of patients with nephrotic syndrome[J].Swiss Medical Weekly,2009,(29-30):416-422.
  • 3Trevisan R,Dodesini AR,Lepore G. Lipids and renal disease[J].Journal of the American Society of Nephrology,2006,(4 Suppl 2):S145-S147.
  • 4Chan CM. Hyperlipidaemia in chronic kidney disease[J].Annals of the Academy of Medicine Singapore,2005,(01):31-35.
  • 5Hu P,Qin YH,Lu L. Genetic variation of apolipoprotein E does not contribute to the lipid abnormalities secondary to childhood minimal change nephrotic syndrome[J].International Urology and Nephrology,2010,(02):453-460.
  • 6Hu P,Lu L,Hu B. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome[J].Scandinavian Journal of Clinical and Laboratory Investigation,2009,(06):680-686.
  • 7Nakamura A,Niimi R,Kurosaki K. Factors influencing cardiovascular risk following termination of glucocorticoid therapy for nephrotic syndrome[J].Clinical and Experimental Nephrology,2010,(05):457-462.
  • 8Park SJ,Shin JI. Complications of nephrotic syndrome[J].Korean J Pediatr,2011,(08):322-328.
  • 9Mahmud S,Jahan S,Hossain MM. Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse[J].Mymensingh Med J,2011,(03):402-406.
  • 10Li HQ,Wu J,Niu DM. The level of native and oxidized lipoprotein (a) in children with nephrotic syndrome[J].Clin B iochem,2012,(1-2):101-105.

共引文献25

同被引文献12

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部